Cryptococcus neoformans laccase catalyses melanin synthesis from both D- and L-DOPA

被引:100
作者
Eisenman, Helene C. [1 ]
Mues, Mascha [1 ]
Weber, Sarah E. [1 ]
Frases, Susana [1 ]
Chaskes, Stuart [2 ]
Gerfen, Gary [3 ]
Casadevall, Arturo [1 ]
机构
[1] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[2] Farmingdale State Coll, Dept Biol, Farmingdale, NY 11735 USA
[3] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA
来源
MICROBIOLOGY-SGM | 2007年 / 153卷
关键词
D O I
10.1099/mic.0.2007/011049-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The human fungal pathogen Cryptococcus neoformans produces melanin in the presence of various substrates, including the L enantiomer of 3,4-dihydroxyphenylalanine (DOPA). The enzyme laccase catalyses the formation of melanin by oxidizing L-DOPA, initiating a series of presumably spontaneous reactions that ultimately leads to the polymerization of the pigment in the yeast cell wall. There, melanin protects the cell from a multitude of environmental and host assaults. Thus, the ability of C. neoformans to produce pigments from a variety of available substrates is likely to confer a survival advantage. A number of C. neoformans isolates of different serotypes produced pigments from D-DOPA, the stereoisomer Of L-DOPA. Acid-resistant particles were isolated from pigmented C. neoformans cells grown in the presence Of D-DOPA. Biophysical characterization showed the particles had a stably detectable free-radical signal by EPR, and negative zeta potential, similar to L-DOPA-derived particles. No major differences were found between L- and D-DOPA ghosts in terms of binding to anti-melanin antibodies, or in overall architecture when imaged by electron microscopy. C. neoformans cells utilized L- and D-DOPA at a similar rate. Overall, our results indicate that C. neoformans shows little stereoselectivity for utilizing DOPA in melanin synthesis. The ability of C. neoformans to use both L and D enantiomers; for melanization implies that this organism has access to a greater potential pool of substrates for melanin synthesis, and this could potentially be exploited in the design of therapeutic inhibitors of laccase.
引用
收藏
页码:3954 / 3962
页数:9
相关论文
共 38 条
[1]   Fungal melanins: a review [J].
Butler, MJ ;
Day, AW .
CANADIAN JOURNAL OF MICROBIOLOGY, 1998, 44 (12) :1115-1136
[2]   STEREOCHEMICAL DETERMINANTS OF THE NATURE AND CONSEQUENCES OF DRUG-METABOLISM [J].
CALDWELL, J .
JOURNAL OF CHROMATOGRAPHY A, 1995, 694 (01) :39-48
[3]   'Ready made' virulence and 'dual use' virulence factors in pathogenic environmental fungi -: the Cryptococcus neoformans paradigm [J].
Casadevall, A ;
Steenbergen, JN ;
Nosanchuk, JD .
CURRENT OPINION IN MICROBIOLOGY, 2003, 6 (04) :332-337
[4]   COMPLEMENTATION OF A CAPSULE-DEFICIENT MUTATION OF CRYPTOCOCCUS-NEOFORMANS RESTORES ITS VIRULENCE [J].
CHANG, YC ;
KWONCHUNG, KJ .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (07) :4912-4919
[5]   A DL-DOPA DROP TEST FOR THE IDENTIFICATION OF CRYPTOCOCCUS NEOFORMANS [J].
CHASKES, S ;
EDBERG, SC ;
SINGER, JM .
MYCOPATHOLOGIA, 1981, 74 (03) :143-148
[6]  
CHASKES S, 2006, AM SOC MICR 106 GEN
[7]   Melanin in the dimorphic fungal pathogen Paracoccidioides brasiliensis:: effects on phagocytosis, intracellular resistance and drug susceptibility [J].
da Silva, MB ;
Marques, AF ;
Nosanchuk, JD ;
Casadevall, A ;
Travassos, LR ;
Taborda, CP .
MICROBES AND INFECTION, 2006, 8 (01) :197-205
[8]   Melanin as a potential cryptococcal defence against microbicidal proteins [J].
Doering, TL ;
Nosanchuk, JD ;
Roberts, WK ;
Casadevall, A .
MEDICAL MYCOLOGY, 1999, 37 (03) :175-181
[9]   Microstructure of cell wall-associated melanin in the human pathogenic fungus cryptococcus neoformans [J].
Eisenman, HC ;
Nosanchuk, JD ;
Webber, JBW ;
Emerson, RJ ;
Camesano, TA ;
Casadevall, A .
BIOCHEMISTRY, 2005, 44 (10) :3683-3693
[10]   A STANDARDIZED TEST FOR THE IDENTIFICATION AND CHARACTERIZATION OF MELANINS USING ELECTRON-PARAMAGNETIC-RESONANCE (EPR) SPECTROSCOPY [J].
ENOCHS, WS ;
NILGES, MJ ;
SWARTZ, HM .
PIGMENT CELL RESEARCH, 1993, 6 (02) :91-99